Rezolute (RZLT) Common Equity (2010 - 2026)
Rezolute (RZLT) reported Common Equity of $100.69 million for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 37.9% from $162.13 million a year earlier and down 13.8% from the prior quarter.
Powered by 
Analysis
Rezolute (RZLT) Common Equity (2010 - 2026) Analysis & Trends
Dating back to fiscal Q2 2011, Rezolute's Common Equity record includes 58 quarters.
- Common Equity has a five-year compound annual growth rate of 31.0% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $162.13 million in FY2025 (+34.0%), $121 million in FY2024 (+4.2%), $116.17 million in FY2023 (-22.3%) and $149.47 million in FY2022 (+472.7%).
- The fiscal Q4 2026 figure ranks as the lowest quarterly Common Equity since fiscal Q3 2025.
- Year over year, Common Equity gained in seven of the last eight quarters, with growth averaging 16.3%.
- The high point for year-over-year Common Equity in five years was fiscal Q1 2023 (growth of 610.1%); the low point was fiscal Q3 2024 (a decline of 44.3%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $116.83 million (Q3 2026), $128 million (Q2 2026) and $147.17 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Rezolute | 394.30 Mn | 394.30 Mn | - | 100.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 100.69 Mn |
| Mar 31, 2026 | 116.83 Mn |
| Dec 31, 2025 | 128.00 Mn |
| Sep 30, 2025 | 147.17 Mn |
| Jun 30, 2025 | 162.13 Mn |
| Mar 31, 2025 | 82.57 Mn |
| Dec 31, 2024 | 99.59 Mn |
| Sep 30, 2024 | 113.44 Mn |
| Jun 30, 2024 | 121.00 Mn |
| Mar 31, 2024 | 70.86 Mn |
| Dec 31, 2023 | 91.73 Mn |
| Sep 30, 2023 | 103.56 Mn |
| Jun 30, 2023 | 116.17 Mn |
| Mar 31, 2023 | 127.32 Mn |
| Dec 31, 2022 | 141.27 Mn |
| Sep 30, 2022 | 153.09 Mn |
| Jun 30, 2022 | 149.47 Mn |
| Mar 31, 2022 | 51.91 Mn |
| Dec 31, 2021 | 62.27 Mn |
| Sep 30, 2021 | 21.56 Mn |
API Access
Rezolute Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RZLT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RZLT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RZLT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();